Breast Cancer Monitoring
December 9th, 2008 | by admin |
- HALO is a microscopic cellular test for breast cancer risk. This 5 minute test determines whether or not there are abnormal cells in the breast ducts. HALO is recommended for women age 25 and older as part of their annual exam. This new method of breast cancer risk monitoring adds an extra layer of safety to every woman’s life. Learn more at:
Tags: Abnormal, Annual, Breast, Cancer, Cells, Cellular, Determination, Ducts, Exam, Halo, Microscopic, Monitoring, Neomatrix, Risk, Test
